Market Overview:
The global aciclovir market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The patent segment is expected to dominate the global aciclovir market in terms of revenue share during the forecast period. The hospital application segment is projected to be the fastest-growing application segment during the forecast period. North America accounted for the largest share of the global aciclovir market in 2017, followed by Europe and Asia Pacific.
Product Definition:
Aciclovir is a synthetic purine nucleoside analog, it is a guanosine analogue. It is used in the treatment of herpes simplex virus infections, including genital herpes, cold sores, and shingles.
Generic:
Aciclovir is a generic medicine, also known as acyclovir or 5-aminolevulinic acid. It's the most widely prescribed antiviral medication in the world and has been used to treat several viral infections, including shingles (herpes zoster), cytomegalovirus infection of the liver and kidneys, chickenpox, measles/meningitis virus infections in children as well as adults.
Patent:
Patent is a legal right granted to the owner of an original design or discovery. In the pharmaceutical industry, patents are primarily used for drug development and marketing processes. Patent protection is given to drugs, chemical compounds, diagnostic methods, and medical devices.
Application Insights:
The drug store application segment led the global aciclovir market in 2017. This can be attributed to increasing awareness about STDs and rising number of HIV cases. According to UNAIDS, around 37 million people were living with HIV across the globe in 2017, with approximately 1.6 million new infections occurring that year alone. In addition, as per WHO estimates, there were around 52 million new cases of chlamydia and nearly 2 billion occasions of bacterial vaginosis worldwide in 2016.
On the other hand, hospital applications accounted for a significant share owing to growing prevalence of various diseases including chickenpox.
Regional Analysis:
North America was the largest market for aciclovir in 2016, with a revenue share of around 57.0%. The region is expected to maintain its dominance over the forecast period owing to increasing cases of Herpes Simplex Virus (HSV) infections and rising awareness about early diagnosis. In addition, growing healthcare expenditure by the government and an increase in per capita income are some factors that can be attributed to this dominance.
Asia Pacific is anticipated to witness significant growth during the forecast period due to increasing disposable income levels and improving healthcare infrastructure in emerging countries such as China & India. Moreover, high unmet medical needs coupled with rapidly expanding pharmaceutical markets are likely reasons for further investment by global players in this region which will also drive growth over next eight years till 2030 time frame.
Growth Factors:
- Increasing incidence of herpes infections: The major growth driver for the aciclovir market is the increasing incidence of herpes infections. Aciclovir is one of the most effective drugs in treating herpes infections and its demand is expected to rise in the coming years.
- Rising awareness about aciclovir: There is a growing awareness among people about the benefits of using aciclovir for treating various types of herpes infections. This is likely to boost demand for this drug in the coming years.
- Growing use of antiviral drugs: The increasing use of antiviral drugs across the world is another key growth driver for the aciclovir market. Aciclovir has emerged as one of most popular antiviral drugs and its demand is expected to grow significantly in future years.
- Technological advancements: The development and introduction new technologies that can improve delivery or efficacy profileofacitcloviris another key factor fuellinggrowthoftheacitclovirmarket .Thisislikelytoresultinanincreaseddemandforthisdruginthecomingyears..5, Availabilityofgenericversions:Theavailabilityofgenericversionsoftheadvanceddrugs suchasacitclovirisanotherfactorpromotinggrowthofthemarket .Thissuggeststhatthedrugisbecomingmoreaccessibletothegeneralpublicanditsdemandisexpectedtocontinuegrowinginthefuture
Scope Of The Report
Report Attributes
Report Details
Report Title
Aciclovir Market Research Report
By Type
Generic, Patent
By Application
Hospital, Drug Store
By Companies
Greater Pharma, LBS Labs, GlaxoSmithKline, Lex Ano, Salutas, Novartis, Teva, Stada Nordic, Cimed Industria de Medicamentos, Reman Drug, L.E.T.I., Nichi-Iko Pharmaceutical, Choseido Pharmaceutical, Shiono Kemikaru, Towa Yakuhin, Wockhardt, Takata Pharmaceutical, Aliud, Amneal Pharma, Apotex, Arrow, Laboratoires Servier, Sanofi, Mylan, Orion Pharma, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
159
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Aciclovir Market Report Segments:
The global Aciclovir market is segmented on the basis of:
Types
Generic, Patent
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Greater Pharma
- LBS Labs
- GlaxoSmithKline
- Lex Ano
- Salutas
- Novartis
- Teva
- Stada Nordic
- Cimed Industria de Medicamentos
- Reman Drug
- L.E.T.I.
- Nichi-Iko Pharmaceutical
- Choseido Pharmaceutical
- Shiono Kemikaru
- Towa Yakuhin
- Wockhardt
- Takata Pharmaceutical
- Aliud
- Amneal Pharma
- Apotex
- Arrow
- Laboratoires Servier
- Sanofi
- Mylan
- Orion Pharma
- Pfizer
Highlights of The Aciclovir Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Generic
- Patent
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Aciclovir Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Aciclovir is an antiviral medication used to treat herpes simplex virus (HSV) infections. It is also used to prevent HSV infections in people who are at high risk for them, such as those with AIDS or cancer. Aciclovir can be taken by mouth or applied topically to the skin.
Some of the major companies in the aciclovir market are Greater Pharma, LBS Labs, GlaxoSmithKline, Lex Ano, Salutas, Novartis, Teva, Stada Nordic, Cimed Industria de Medicamentos, Reman Drug, L.E.T.I., Nichi-Iko Pharmaceutical, Choseido Pharmaceutical, Shiono Kemikaru, Towa Yakuhin, Wockhardt, Takata Pharmaceutical, Aliud, Amneal Pharma, Apotex, Arrow, Laboratoires Servier, Sanofi, Mylan, Orion Pharma, Pfizer.
The aciclovir market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Aciclovir Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Aciclovir Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Aciclovir Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Aciclovir Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Aciclovir Market Size & Forecast, 2018-2028
4.5.1 Aciclovir Market Size and Y-o-Y Growth
4.5.2 Aciclovir Market Absolute $ Opportunity
Chapter 5 Global Aciclovir Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Aciclovir Market Size Forecast by Type
5.2.1 Generic
5.2.2 Patent
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Aciclovir Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Aciclovir Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Aciclovir Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Aciclovir Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Aciclovir Analysis and Forecast
9.1 Introduction
9.2 North America Aciclovir Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Aciclovir Market Size Forecast by Type
9.6.1 Generic
9.6.2 Patent
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Aciclovir Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Aciclovir Analysis and Forecast
10.1 Introduction
10.2 Europe Aciclovir Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Aciclovir Market Size Forecast by Type
10.6.1 Generic
10.6.2 Patent
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Aciclovir Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Aciclovir Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Aciclovir Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Aciclovir Market Size Forecast by Type
11.6.1 Generic
11.6.2 Patent
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Aciclovir Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Aciclovir Analysis and Forecast
12.1 Introduction
12.2 Latin America Aciclovir Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Aciclovir Market Size Forecast by Type
12.6.1 Generic
12.6.2 Patent
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Aciclovir Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Aciclovir Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Aciclovir Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Aciclovir Market Size Forecast by Type
13.6.1 Generic
13.6.2 Patent
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Aciclovir Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Aciclovir Market: Competitive Dashboard
14.2 Global Aciclovir Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Greater Pharma
14.3.2 LBS Labs
14.3.3 GlaxoSmithKline
14.3.4 Lex Ano
14.3.5 Salutas
14.3.6 Novartis
14.3.7 Teva
14.3.8 Stada Nordic
14.3.9 Cimed Industria de Medicamentos
14.3.10 Reman Drug
14.3.11 L.E.T.I.
14.3.12 Nichi-Iko Pharmaceutical
14.3.13 Choseido Pharmaceutical
14.3.14 Shiono Kemikaru
14.3.15 Towa Yakuhin
14.3.16 Wockhardt
14.3.17 Takata Pharmaceutical
14.3.18 Aliud
14.3.19 Amneal Pharma
14.3.20 Apotex
14.3.21 Arrow
14.3.22 Laboratoires Servier
14.3.23 Sanofi
14.3.24 Mylan
14.3.25 Orion Pharma
14.3.26 Pfizer
